- Home
- GVH vs INAB Comparison
GVH vs INAB Comparison
Compare GVH & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GVH
- INAB
- Stock Information
- Founded
- GVH 2016
- INAB 2016
- Country
- GVH Australia
- INAB United States
- Employees
- GVH N/A
- INAB N/A
- Industry
- GVH
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- GVH
- INAB Health Care
- Exchange
- GVH Nasdaq
- INAB Nasdaq
- Market Cap
- GVH N/A
- INAB 24.0M
- IPO Year
- GVH 2023
- INAB 2021
- Fundamental
- Price
- GVH $0.64
- INAB $0.25
- Analyst Decision
- GVH
- INAB Strong Buy
- Analyst Count
- GVH 0
- INAB 3
- Target Price
- GVH N/A
- INAB $7.75
- AVG Volume (30 Days)
- GVH 22.3K
- INAB 727.4K
- Earning Date
- GVH 02-15-2025
- INAB 11-12-2024
- Dividend Yield
- GVH N/A
- INAB N/A
- EPS Growth
- GVH 67.24
- INAB N/A
- EPS
- GVH 0.11
- INAB N/A
- Revenue
- GVH $17,570,748.00
- INAB N/A
- Revenue This Year
- GVH N/A
- INAB N/A
- Revenue Next Year
- GVH N/A
- INAB N/A
- P/E Ratio
- GVH $5.93
- INAB N/A
- Revenue Growth
- GVH N/A
- INAB N/A
- 52 Week Low
- GVH $0.47
- INAB $0.22
- 52 Week High
- GVH $2.57
- INAB $1.93
- Technical
- Relative Strength Index (RSI)
- GVH 38.16
- INAB 39.26
- Support Level
- GVH $0.66
- INAB $0.28
- Resistance Level
- GVH $0.69
- INAB $0.32
- Average True Range (ATR)
- GVH 0.04
- INAB 0.03
- MACD
- GVH -0.00
- INAB -0.01
- Stochastic Oscillator
- GVH 0.00
- INAB 13.73
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.